Free Trial
TSE:PLI

ProMetic Life Sciences (PLI) Stock Price, News & Analysis

ProMetic Life Sciences logo

About ProMetic Life Sciences Stock (TSE:PLI)

Key Stats

Today's Range
N/A
50-Day Range
C$13.60
C$13.60
52-Week Range
N/A
Volume
921 shs
Average Volume
8,002 shs
Market Capitalization
C$317.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Prometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada.

Receive PLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProMetic Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

PLI Stock News Headlines

TMC Life Sciences Bhd (TMCN)
“This Changes Everything” - Trump Hands Millions Massive IRS Gift
Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…
TSX:CVE (CENOVUS ENERGY INC.)
See More Headlines

PLI Stock Analysis - Frequently Asked Questions

Shares of PLI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProMetic Life Sciences investors own include Nemaska Lithium (NMX), Crescent Point Energy (CPG), ProMetic Life Sciences (PFSCF), Bombardier, Inc. Class B (BBD.B), Sierra Wireless (SWIR), Baytex Energy (BTE) and Dollarama (DOL).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
487
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$39.91 million
Book Value
C$6.07 per share

Miscellaneous

Free Float
N/A
Market Cap
C$317.06 million
Optionable
Not Optionable
Beta
N/A
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (TSE:PLI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners